http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100761222-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45F2200-0516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45F2005-006
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A44B11-2584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45F5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
filingDate 2006-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100761222-B1
titleOfInvention Vanilloid receptor antagonists to prevent and treat drug-dependent addiction
abstract The present invention relates to the prevention and treatment of adverse effects by abused drugs. In particular, the present invention relates to a medicament effective for preventing or treating dependence and spontaneous exercise by drugs acting on vanilloid receptors. The administration of capsazepine acting on the vanilloid receptor used in the present invention exhibits a strong dependence-improving effect on the cocaine-dependent poisoning formation and relapse process. Therefore, the administration of the drug acting on the vanilloid receptor according to the present invention provides important information for the development and prevention of drug-dependent poisoning.n n n n Capsazepine, drug-dependent poisoning, vanilloid receptor
priorityDate 2006-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10836
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ697L1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491246
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID445457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ704Y3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462328
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID193034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453197090
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6R5A3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733484
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8NER1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7442
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6RX08
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507808
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO35433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556542

Total number of triples: 52.